NASDAQ
Gritstone bio, Inc. (GRTS) has a free cash flow growth of 20.37% as of Friday, May 29, 2026. This represents a 349.09% increase compared to its 12-month average of 4.54%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.